Irisin

What is Irisin?

Irisin is an endogenous myokine — a signaling molecule produced by skeletal muscle during exercise. It is generated by proteolytic cleavage of FNDC5 (fibronectin type III domain-containing protein 5), a PGC-1α-regulated membrane protein. First identified by Spiegelman et al. in 2012, irisin drew enormous scientific and public attention as a candidate "exercise hormone" — a molecule that might replicate some of exercise's metabolic benefits by promoting the browning of white adipose tissue (converting energy-storing fat into energy-burning fat). More than a decade later, irisin remains an active research area with legitimate mechanistic findings but substantial controversy over quantification, bioactivity in humans, and therapeutic feasibility.

What Irisin Is Investigated For

Irisin is studied primarily as the exercise-induced myokine responsible for browning of white adipose tissue, with additional preclinical signals in bone formation, neuroprotection (particularly in Alzheimer's models), and glucose regulation. The strongest evidence is for the muscle-PGC-1α-FNDC5-irisin axis itself — the molecule is real, the receptor (integrin αV/β5) is identified, and rodent studies consistently show exogenous irisin induces UCP1 expression and improves glucose tolerance. Human translation is where the story thins: early human quantification was plagued by unreliable antibodies, exercise-induced elevation is inconsistent across studies, and there is no human RCT of exogenous irisin administration for any indication. Irisin is a ~112-residue glycosylated peptide with poor oral bioavailability and no approved therapeutic product, so the practical way to raise levels remains the input that generated the biology in the first place — exercise, particularly resistance training and HIIT. Research-chemical 'irisin' is of unverified purity and is not a validated therapeutic.

How It Works

When you exercise, your muscles release irisin — a hormone that tells white fat cells (which store energy) to become more like brown fat cells (which burn energy). It also appears to signal bone, brain, and metabolic tissues in ways that may replicate some benefits of exercise. The catch: taking irisin as a pill or injection doesn't work well, and the amount your body makes naturally varies a lot between people and training types.

Irisin is produced when exercise activates PGC-1α (a master metabolic transcription coactivator) in skeletal muscle, upregulating FNDC5. The FNDC5 membrane protein is proteolytically cleaved and secreted as a glycosylated ~12 kDa fragment. Irisin binds integrin αV/β5 receptors on target cells, activating downstream signaling that includes p38 MAPK and ERK pathways. In white adipocytes, this induces expression of UCP1 (uncoupling protein 1) and other thermogenic markers, converting them to a "beige" or brown-like phenotype capable of non-shivering thermogenesis. Irisin also acts on osteoblasts (promoting bone formation), hippocampal neurons (increasing BDNF expression, neurogenesis), and pancreatic beta cells (supporting insulin secretion). The controversy around irisin centers on the magnitude of these effects at physiologic concentrations — preclinical studies often use doses orders of magnitude higher than endogenous circulating levels, making translation to therapeutic benefit uncertain.

Evidence Snapshot

Forms & Administration

Irisin is not available as an approved therapy or clinical product. Research grade recombinant irisin is used in laboratory studies. The established way to raise endogenous irisin is regular exercise, particularly high-intensity and resistance training. Adequate protein intake and sleep also support PGC-1α/FNDC5 expression.

Monitoring & Measurement

Common Questions

Safety Profile